Plaintiff

Self-Insured Schools of California

1 case as plaintiff.

Cases
1
Active
0
1 closed
Filed
2020
Top venue
S.D. New York
1 case

Company profile

Self-Insured Schools of California (SISC) is a California joint powers authority (JPA) headquartered at 2000 K Street, Bakersfield, California. It is a public entity, not a private company, and has no ticker. It operates as three separate self-insurance programs — SISC I (workers' compensation), SISC II (property and liability) and SISC III (health and welfare benefits) — formed under California Government Code §§ 990 and 6500 et seq. A 2021 Kern County Grand Jury report states that SISC II was established July 1, 1979; SISC II served 157 member public school agencies in 19 counties, covering roughly 400,000 students and more than $12.8 billion in insured value. California State Controller public-pay records list roughly 20–26 employees per program.

Operations. SISC arranges and administers insurance and risk-management coverage for its member school districts. SISC II is self-administered, providing general liability, automobile, property and student-accident coverage with in-house claims management and excess coverage purchased from outside carriers. SISC I administers workers' compensation, and SISC III administers employee health and welfare benefits (roughly 300,000 covered members, per its own litigation filings). Member districts fund the programs through contributions and premiums. Reported program revenues have ranged from tens of millions (SISC I/II) to over $2 billion (SISC III health benefits).

Litigation posture. SISC is an operating entity, not a patent holder or assertion vehicle. Its single tracked appearance is as a plaintiff — and the suit is an antitrust case, not a patent case: Self-Insured Schools of California v. Jazz Pharmaceuticals PLC, filed August 14, 2020 in the Southern District of New York (7:20-cv-06495). SISC sued as an indirect purchaser (end-payor) of the narcolepsy drug Xyrem, alleging that Jazz's "evergreening" patents, sham citizen petitions, REMS abuse, sham infringement suits and reverse-payment settlements with generic manufacturers delayed generic entry.

Context. The SISC suit was consolidated into an MDL in the Northern District of California; SISC was one of six named class plaintiffs. In April 2025 Jazz agreed to a $145 million settlement resolving the end-payor claims.

Keep this research.

Save to your free workspace, then choose whether to receive updates.